Abstract The Bethesda System for reporting cervical/vaginal diagnoses was introduced to
replace the numerical Papanicolaou class designations, thereby facilitating precise …

Objective: To examine the clinical usefulness of the Bethesda classification system of low-
grade cervicovaginal cytology as it relates to predicting underlying histology and aiding in …

In 1989, a National Cancer Institute workshop resulted in the development of the Bethesda
System for cytologic reporting of Papanicolaou smears. In the Bethesda III System (2001) …

In the Bethesda System, noninvasive squamous abnormalities are classified as atypical
squamous cells of undetermined significance (ASQUS), low-grade squamous intraepithelial …

In December of 1988, the National Cancer Institute in Bethesda, Maryland (USA), held a
workshop that produced published guidelines for reporting the results of cervical and …

Abstract Background. Although the Bethesda System provides concise, specific descriptions
for classifying cervical cytology, its usefulness has been questioned in the United States and …

The 2001 Bethesda System for reporting cervical or vaginal cytologic diagnoses is an
incremental change in the uniform terminology introduced in 1988 and revised in 1991. The …

BACKGROUND Effective communication between pathologist and clinician is a critical, recip-
rocal process that impacts directly on patient care. The clinician is expected to provide …

In March 2012, the College of American Pathologists and American Society for Colposcopy
and Cervical Pathology, in collaboration with 35 stakeholder organizations, convened a …

Abstract In applying the Bethesda System of classification to cervical squamous lesions, we
evaluated the Papanicolaou smears, cervical biopsies, and human papillomavirus (HPV) …